Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07104006 · ClinicalTrials.gov registry record · NA

Smoking Cessation Intervention for Young Adults Using MTM: A Randomized Controlled Trial

A NA study, sponsored by University of Nevada, Las Vegas.

Not yet
Registry status
NA
Development phase
144
Enrollment target

NCT07104006: Clinical Trial NA study, sponsored by University of Nevada, Las Vegas.

NCT07104006 is a NA study that has not yet begun recruiting, run by University of Nevada, Las Vegas. The registered enrollment target is 144 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07104006, a NA study, has not yet begun recruiting, sponsored by University of Nevada, Las Vegas.

NOT YET RECRUITING
Registry status
NA
Development phase
144 participants
Enrollment target

Study Summary

The goal of this clinical trial is to evaluate whether a Multi-Theory Model (MTM)-based behavioral intervention can effectively promote smoking cessation and support behavior change in young adult cigarette smokers aged 18 to 29 in the United States. This trial focuses on whether applying theory-driven strategies such as emotional transformation, behavioral confidence, and participatory dialogue can lead to higher smoking abstinence rates and improved psychosocial outcomes compared to a standard knowledge-based smoking education control group. The main questions it aims to answer are: * Does the intervention lead to a greater reduction in nicotine dependence scores (measured by the Fagerström Test for Nicotine Dependence \[FTND\]) and an increase in quit rate among young adult smokers from baseline to 12-week follow-up? * Does the MTM-based intervention significantly improve 7-day point prevalence abstinence (PPA) at 12 weeks compared to a knowledge-based control group? * Does the intervention result in significant positive changes in MTM constructs such as participatory dialogue, behavioral confidence, emotional transformation, practice for change, and changes in the physical and social environment from baseline to 12-week follow-up? Researchers will compare the MTM-based intervention group (experimental arm) to a knowledge-based smoking education control group to determine whether the theory-driven program is more effective in supporting smoking cessation and behavior change among young adult smokers. Participants will: * Complete surveys at three time points: baseline (Week 0), post-intervention (Week 5), and follow-up (Week 12), covering demographics, smoking history, nicotine dependence (FTND), MTM constructs (via a validated 48-item scale), and self-reported quit rates. * Be randomly assigned to one of two groups: o MTM-Based Intervention Group: Attend four weekly 90-minute virtual group sessions covering: Week 1: Participatory dialogue, behavioral conf

Primary Outcome

This outcome measures changes in nicotine dependence using the Fagerström Test for Nicotine Dependence (FTND), a validated 6-item questionnaire assessing the intensity of physical addiction to nicotine. Scores range from 0 to 10, with higher scores indicating greater dependence. Participants complete the FTND at baseline (pre-intervention) and again at the 12-week follow-up. The difference in scores over time is used to evaluate whether the intervention reduces nicotine dependence among young ad

Interventions

  • BEHAVIORAL Multi-Theory Model (MTM)-Based Smoking Cessation Program

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2025-11-01
Est. Completion 2026-03-01
Phase NA
University of Nevada, Las Vegas

52 total trials

What is known before NCT07104006 opens enrollment

NCT07104006 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 1 intervention - of which Multi-Theory Model (MTM)-Based Smoking Cessation Program is the first listed.

NCT07104006 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07104006 about?

NCT07104006 is a clinical study titled "Smoking Cessation Intervention for Young Adults Using MTM: A Randomized Controlled Trial". The goal of this clinical trial is to evaluate whether a Multi-Theory Model (MTM)-based behavioral intervention can effectively promote smoking cessation and support behavior change in young adult cigarette smokers aged 18 to 29 in the United States. This trial focuses on whether applying theory-dri...

What is the current status of trial NCT07104006?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2025-11-01. Estimated completion is 2026-03-01.

What interventions are being tested in trial NCT07104006?

The interventions under investigation include: Multi-Theory Model (MTM)-Based Smoking Cessation Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT07104006?

This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07104006's enrollment target sits among peer trials

144 706th of 2000 higher than 1,290 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01861106 · 144 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

  • NCT03482245 · 144 participants · NA

    The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

  • NCT03504683 · 144 participants · NA

    MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes

  • NCT03905603 · 144 participants · Early Phase 1

    Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07104006, the US trial registry maintained by the National Library of Medicine. NCT07104006 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.